Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
gp120 is a glycoprotein found on the surface of the Human Immunodeficiency Virus (HIV) envelope. It plays a critical role in viral entry by mediating attachment to host cell receptors, primarily CD4, and facilitating subsequent steps leading to membrane fusion and infection. The name "gp120" refers to its approximate molecular weight of 120 kDa. It associates non-covalently with gp41 to form trimeric spikes on the viral envelope. gp120 is a major target for neutralizing antibodies but has proven difficult as an effective vaccine antigen due to its conformational flexibility, extensive glycan shield, and rapid sequence variation.
Attachment to CD4 and co-receptors on host cells, leading to membrane fusion and viral entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on gp120 Attachment Protein (gp120).